Back

Utility of KAsH score in predicting in-hospital mortality in takotsubo cardiomyopathy

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 5 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Isabel Martins Moreira

Hospital Center of Tras-os-Montes and Alto Douro, Vila Real (Portugal)

7 More presentations in this session

Presentation thumbnail
Design and rationale for MAGNITUDE, a phase 3, randomised, placebo-controlled trial of NTLA-2001, a CRISPR-based gene editing therapy, in patients with transthyretin amyloidosis with cardiomyopathy
Doctor M. Maurer (New York, US)
Abstract Slides Video
Presentation thumbnail
T-Amylo score for the diagnosis of transthyretin cardiac amyloidosis in patients with acute heart failure.
Ms M. Diez (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Prevalence, clinical significance and prognosis value of liver stiffness measurement anomalies in transthyretin cardiac amyloidosis
Mrs E. Lointier (Toulouse, FR)
Abstract Slides Video
Presentation thumbnail
Right ventricular to pulmonary artery uncoupling is an early predictor of poor outcome in wild-type transthyretin cardiac amyloidosis
Doctor G. Sinigiani (Padua, IT)
Abstract Slides Video
Presentation thumbnail
Impairment of right ventricular to pulmonary artery coupling is associated with worse survival in cardiac amyloidosis
Doctor A. Jakstaite (Hannover, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial disease - clinical 5

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Utility of the InterTAK prognostic score in predicting mortality in Takotsubo cardiomyopathy
thumbnail
Congress Presentation
Contemporary characteristics, outcomes and novel risk score for Takotsubo cardiomyopathy: a national inpatient sample analysis
thumbnail
Congress Presentation
Cardiovascular and non-cardiovascular prescribing and mortality after takotsubo

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources